Literature DB >> 752263

Red-cell hypoplasia and increased bone marrow reticulin in systemic lupus erythematosus: reversal with corticosteroid therapy.

J Cavalcant, R K Shadduck, A Winkelstein, Z Zeigler, H Mendelow.   

Abstract

A 29-year-old Chinese male developed severe aregenerative anemia. The bone marrow was diffusely hypercellular with increased marrow reticulin and a persistent failure of erythroid differentiation beyond the pronormoblast stage. Although he did not manifest classic features of systemic lupus erythematosus, multiple serologic studies were in accord with this diagnosis. The patient's defect in erythropoiesis was studied by an in vitro technique for the growth of erythroid colonies. Despite the severe erythroid hypoplasia, the patient's marrow yielded abundant large erythroid colonies. Serum erythropoietin activity was high as judged by use of this in vitro assay. Although the patient's native serum did not affect colony formation, a separated IgG fraction was markedly inhibitory to colony growth. This suggests that the erythroid hypoplasia may have resulted from a unique autoantibody. The patient's hematologic abnormalities completely reversed following treatment with corticosteroids.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 752263     DOI: 10.1002/ajh.2830050310

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  8 in total

Review 1.  Lessons learned from bone marrow failure in systemic lupus erythematosus: Case reports and review of the literature.

Authors:  Erik Anderson; Bhakti Shah; Anne Davidson; Richard Furie
Journal:  Semin Arthritis Rheum       Date:  2017-12-08       Impact factor: 5.532

2.  Pure red-cell aplasia: association with systemic lupus erythematosus and primary autoimmune hypothyroidism.

Authors:  D A Francis
Journal:  Br Med J (Clin Res Ed)       Date:  1982-01-09

3.  T gamma (T gamma) cells suppress growth of erythroid colony-forming units in vitro in the pure red cell aplasia of B-cell chronic lymphocytic leukemia.

Authors:  K F Mangan; G Chikkappa; P C Farley
Journal:  J Clin Invest       Date:  1982-12       Impact factor: 14.808

4.  Antibody-dependent cellular cytotoxicity to allogeneic but not autologous erythroblasts in vitro.

Authors:  S B Krantz; E N Dessypris
Journal:  J Clin Immunol       Date:  1982-07       Impact factor: 8.317

Review 5.  Systemic lupus erythematosus and myelofibrosis.

Authors:  C Matsouka; J Liouris; A Andrianakos; C Papademetriou; G Karvountzis
Journal:  Clin Rheumatol       Date:  1989-09       Impact factor: 2.980

6.  Indoprofen-induced aplastic anemia in active connective tissue disease detected by drug-specific lymphocyte transformation.

Authors:  J G Saal; P T Daniel; P A Berg
Journal:  Klin Wochenschr       Date:  1986-05-15

Review 7.  Bone marrow fibrosis as a feature of systemic lupus erythematosus: a case report and literature review.

Authors:  Emilie Chalayer; Martine Ffrench; Pascal Cathébras
Journal:  Springerplus       Date:  2014-07-09

8.  Variable in vitro erythropoiesis in patients with transient erythroblastopenia of childhood.

Authors:  A K Ritchey; N Dainiak; R Hoffman
Journal:  Yale J Biol Med       Date:  1985 Jan-Feb
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.